Gingival overgrowth is also known as gingival hyperplasia or

Gingival overgrowth is also known as gingival hyperplasia or gingival fibromatosis, it is usually associated with multiple factors including inflammation, drug use, neoplasias, hormonal disturbances, uncontrolled diabetes and blood dyscrasias [3–5]. In rare cases (1 in 750,000 people), the overgrowth can be hereditary or associated with unknown pathogenesis, hence the former are described as hereditary gingival fibromatosis (HGF) while the others recognized as idiopathic gingival fibromatosis (IGF) [6,7]. Most HGF cases are probably caused by genetic disorders, and therefore should not be called idiopathic, usually identified by significant family history. HGF can occur as isolated disease affecting only the gingiva or as part of a syndrome or chromosomal abnormality, transmitted as autosomal dominant trait in which two gene loci on the short arm of chromosome 2 where identified in a Brazilian family [8,9]. Drug induced gingival overgrowth (DIGO) is a side effect and unwanted outcome of systemic medications and is limited to gingival tissue. This is most obvious in the cases of organ transplant recipient who require continuous therapy with immunosuppressive agents, primarily cyclosporine A (CsA), its clinical use is often complicated by several well documented systemic and oral side effects. In the last years, Tacrolimus (TAC/FK506) have been introduced as a new immunosuppressive agents, it has been successfully used as an alternative to CsA with limited systemic and oral side effects [10,11]. DIGO is a pathology characterized by increased deposition of extracellular matrix (ECM) components particularly interstitial collagen (COL), together with altered (COL) turnover may be the main switch for (GO) development [12,13]. In HGF, the histological characteristics suggest that the expansion of gingival tissue results mostly from increased ECM accumulation, since the tissue is rich in collagen, associated with relatively few fibroblasts. In addition to increased proliferation of epithelial Ro 31-8220 methanesulfonate Supplier may account for the formation of elongated rete pegs [14]. It is well known, that (ECM) is an important regulation to cell functions, and it also serves as storage for various growth factors and participates in the regulation of their activation. Thus, altered abundance or composition of ECM may play an active part in the pathogenesis of GO in both HGF and DIGO [15,16]. In addition, the content of the interstitial collagen 1 (COL-1) which is the major components of ECM is mainly determined by the finely tuned balance between synthesis and degradation mediated by matrix metalloproteinases (MMPs), which are the metabolism of extracellular components. Disturbance in the physiological balance between MMPs and their endogenous serum and tissue inhibitors of metalloproteinases (TIMPs) is implicated in several inflammatory disorders. The major serum inhibitor is α2-macroglobulin, which covalently crosslink with and inactivates target MMPs while tissue inhibitors of MMPs to their active forms. In general, any derangement in the regulatory mechanism controlling MMPs and their inhibitors collagen may increase, leading to GO [17–19]. In fact, connective tissue turnover is largely controlled by chemokines and cytokines secreted by inflammatory cells such as macrophages and lymphocytes and to a lesser degree by fibroblasts. It has been shown that in Go tissues, there are abnormally high levels of specific cytokines including interleukin-6 (IL-6), (IL-Iβ), Transforming Growth factor (TGF-β1), Platelet Derived Growth Factor-B (PDGF-B), Fibroblast Growth Factor-2 (FGF-2) and Connective Tissue Growth Factor (CTGF) [20,21]. In this tightly regulated mechanism, TGF-β1 is the major mediator influencing collagen turnover. There are three isoforms of TGF-β family (β1, β2, β3) that are expressed in humans to stimulate fibroblast proliferation and deposition of ECM, it also regulate various functions of epithelial cells, including cell migration, proliferation and gene expression. The functions of different isoforms are distinct, since TGF-β1 and TGF-β2 are involved in the development of fibrosis, while TGF-β3 appears to prevent it. Almost all human cells synthesize TGF-β1and have receptors for it, alpha granules of platelets and macrophages are the most concentrated source of TGF-β1 [22,23].